Auriga Partners

About The Fund

Auriga Partners is a French venture capital firm established in 1998, positioned as a pioneer in the venture capital landscape of France. Operating out of Paris, they focus on investing in innovative companies within the information, communication technology, and life sciences sectors. Their investment strategy encompasses a range of industries including Software (e.g., Web Marketplace, SaaS), IT & TMT, BioTech, Hardware & Manufacturing, IoT & Wearables, A.I. & Big Data, Material Science, Medical Devices & Hospital Services, Life Science, and Oncology. Auriga Partners proudly highlights their status as an equity investor with a particular specialty in Seed, Startup, and Early Stage ventures. They aim to support entrepreneurs from the inception of their ideas through all the growth phases of their businesses, including important exit events such as trade sales and IPOs. Boasting an assets under management (AUM) sum of 400 million euros, they have deployed investments ranging from 1 million euros to a maximum of 8.18 million euros in more than 120 companies over the years, leading to 50 trade sales and IPOs. This investor champions innovation—whether incremental or disruptive—as a catalyst for positive change, leveraging collective intelligence by integrating specific expertise on forward-looking themes or territories. The collective intelligence is a key part of their investment leverage, ensuring that a diverse range of expertise and talents contribute to the future-focused themes they invest in.